ArticleInfection and drug resistance2026
Exosomal miR-148a-3p from LPS-Activated Macrophages Promotes M1 Polarization and Ferroptosis-Related Characteristics of Recipient Macrophages by Reducing SLC7A11.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gram-negative bacterial infection is a major cause of severe inflammatory disorders and cellular damage, with lipopolysaccharide (LPS) as a key pathogenic trigger. Macrophages are central players in LPS-induced inflammatory cascades, yet the mechanisms by which macrophage-derived exosomes propagate inflammatory signals and cellular injury remain elusive. This study aimed to investigate whether LPS-activated macrophage exosomes drive M1 polarization and ferroptosis-related characteristics in recipient macrophages. Methods: RAW264.7 macrophages were treated with LPS. Exosomes were extracted through ultracentrifugation and their characteristics were determined utilizing Western blot, transmission electron microscopy, and nanoparticle tracking analysis. MicroRNA levels were quantified by droplet digital PCR. The functional effects of exosomes and miR-148a-3p inhibitor on recipient macrophages were evaluated via quantitative real-time PCR, Western blot, enzyme-linked immunosorbent assay, malondialdehyde (MDA) detection and ferrostatin-1 (Fer-1) rescue assay. Dual-luciferase reporter assay validated direct targeting relationships. Results: LPS directly induced M1 polarization and pro-inflammatory cytokine secretion in RAW264.7 cells. Exosomes from LPS-stimulated macrophages were enriched with miR-148a-3p and promoted M1 polarization and ferroptosis-related characteristics in recipient cells. Inhibition of miR-148a-3p and Fer-1 treatment effectively negated the LPS-exosome-mediated effects. Mechanistically, miR-148a-3p directly interacted with and inhibited SLC7A11. Conclusion: Exosomal miR-148a-3p derived from LPS-activated macrophages promotes M1 polarization and ferroptosis-related characteristics in recipient macrophages by reducing SLC7A11. This finding uncovers a novel LPS-induced inflammatory signaling pathway in macrophage-macrophage communication and suggests a potential candidate target for intervention in Gram-negative bacteria-related inflammatory injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.